My paper “Determinants of pharmaceutical innovation: the role of technological opportunities revisited” is now available online as a forthcoming article in the Journal of Evolutionary Economics. In this paper I analyze the role of market size as well as of technological opportunities for pharmaceutical innovations. The empirical analyses reveal a rather robust and significantly positive response of the number of new pharmaceuticals, i.e., new molecular entities or new drug approvals, to market size and technological opportunities. The paper is available here.